U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Food
  3. News & Events from HFP
  4. Workshops, Meetings & Webinars on Food and Dietary Supplements
  5. Stakeholder Webinar on the Draft Guidance for Industry on Action Levels for Lead in Juice - 06/14/2022
  1. Workshops, Meetings & Webinars on Food and Dietary Supplements

Webcast | Virtual

Event Title
Stakeholder Webinar on the Draft Guidance for Industry on Action Levels for Lead in Juice
June 14, 2022

Date:
June 14, 2022
Time:
1:00 p.m. - 2:00 p.m. ET

The U.S. Food and Drug Administration (FDA) hosted a webinar on Tuesday, June 14, 2022, at 1:00 pm (ET) to discuss the recent draft guidance on lead action levels for juice. The draft guidance, titled “Action Levels for Lead in Juice; Draft Guidance for Industry,” issued in April and provides action levels for lead in single-strength (ready to drink) apple juice and in other single-strength juices and juice blends. These draft action levels support the agency’s broader effort to reduce exposure to arsenic, lead, cadmium, and mercury from foods, and advance our goals in the Closer to Zero action plan.

During the webinar the FDA provided an overview of the draft guidance and additional information, as well as answered stakeholder questions.

Featured speakers included Dr. Susan Mayne, Director, Center for Food Safety & Applied Nutrition (CFSAN), Dr. Conrad Choiniere, Director, Office of Analytics and Outreach, CFSAN, and Dr. Paul South, Director, Division of Plant Products and Beverages, Office of Food Safety, CFSAN.

Agenda

  • Meeting Overview and Opening Remarks (Dr. Susan Mayne) 3 minutes
  • Overview of the draft guidance on action levels for lead in juice (Dr. Paul South) 10 minutes
  • First -year accomplishments and what’s ahead this year (Dr. Conrad Choiniere) 5 minutes
  • Stakeholder Q&A (with panel) 25 minutes
  • Closing (FDA) 2 minutes

Webinar Recording

Transcript (PDF: 128KB)

Back to Top